Nutriband Inc. Warrant
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA b… Read more
Nutriband Inc. Warrant (NTRBW) - Total Assets
Latest total assets as of July 2025: $10.18 Million USD
Based on the latest financial reports, Nutriband Inc. Warrant (NTRBW) holds total assets worth $10.18 Million USD as of July 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nutriband Inc. Warrant - Total Assets Trend (2016–2025)
This chart illustrates how Nutriband Inc. Warrant’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nutriband Inc. Warrant - Asset Composition Analysis
Current Asset Composition (January 2025)
Nutriband Inc. Warrant's total assets of $10.18 Million consist of 64.2% current assets and 35.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 57.7% |
| Accounts Receivable | $73.85K | 1.0% |
| Inventory | $212.04K | 2.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $261.09K | 3.5% |
| Goodwill | $1.72 Million | 23.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Nutriband Inc. Warrant's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nutriband Inc. Warrant's current assets represent 64.2% of total assets in 2025, a decrease from 100.0% in 2016.
- Cash Position: Cash and equivalents constituted 57.7% of total assets in 2025, up from 30.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 23.0% of total assets.
Nutriband Inc. Warrant Competitors by Total Assets
Key competitors of Nutriband Inc. Warrant based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Nutriband Inc. Warrant - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nutriband Inc. Warrant generates 0.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nutriband Inc. Warrant is currently not profitable relative to its asset base.
Nutriband Inc. Warrant - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.78 | 6.57 | 0.13 |
| Quick Ratio | 4.70 | 6.36 | 0.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.95 Million | $ 6.14 Million | $ -2.23 Million |
Nutriband Inc. Warrant - Advanced Valuation Insights
This section examines the relationship between Nutriband Inc. Warrant's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.69 |
| Asset Growth Rate (YoY) | -0.6% |
| Total Assets | $7.47 Million |
| Market Capitalization | $5.18 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nutriband Inc. Warrant's assets below their book value (0.69 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Nutriband Inc. Warrant's assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Nutriband Inc. Warrant (2016–2025)
The table below shows the annual total assets of Nutriband Inc. Warrant from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-01-31 | $7.47 Million | -0.63% |
| 2024-01-31 | $7.52 Million | -20.51% |
| 2023-01-31 | $9.46 Million | -25.77% |
| 2022-01-31 | $12.74 Million | +28.33% |
| 2021-01-31 | $9.93 Million | +351.71% |
| 2020-01-31 | $2.20 Million | -21.72% |
| 2019-01-31 | $2.81 Million | +1602.63% |
| 2018-01-31 | $164.90K | +337.08% |
| 2017-01-31 | $37.73K | +11332.42% |
| 2016-01-31 | $330.00 | -- |